CAS: 1346704-33-3; 1-Isopropyl-N-((6-Methyl-2-Oxo-4-Propyl-1,2-Dihydropyridin-3-yl)Methyl)-6-(2-(4-Methylpiperazin-1-yl)Pyridin-4-yl)-1H-Indazole-4-Carboxamide

该化合物是一个小分子抑制剂,主要以其在调控进化过程中的作用而闻名,具体针对的是酶EZH2,这是聚氯压压抑综合体2(PRC2)的一个组成部分,并参与在赖氨27(H3K27)对正丙酮H3进行甲基化,这种甲基化对于基因静默和对各种生物过程(包括发育和区别)的管理至关重要.GSK 343已经研究过其在癌症治疗中的潜在治疗应用,特别是在EZH2基因突变肿瘤中.EZH2的复合显示EZH2相对于其他甲基转移酶的选择性,使其成为研究和药物开发的宝贵工具.此外,它影响基因表达模式的能力将它定位为进一步探索肾脏疗法的重要候选物.与许多调查性化合物一样,GSK343的安全和功效是正在进行的研究的主题.

结构式图片

欧盟法规

C&L通报

上下游产品

6-bromo-1-(1-methylethyl)-1H-indazole-4-carboxylic acid 1-methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-yl)piperazine 6-bomo-1-(1-methylethyl)-N-[(6-methyl-2-oxo-4-propyl-1,2-dihydro-3-pyridinyl)methyl]-1H-indazole-4-carboxamide 3-(aminomethyl)-6-methyl-4-propyl-2(1H)-pyridinone

合成工艺路线路线简述

    📜6-溴-4-吲唑甲酸甲酯置于n-甲基吗啉,N-羟基-7-氮杂苯并三氮唑,1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物,Sodium Hydride,碳酸氢钠,盐酸-N-乙基-N'-(3-二甲氨基丙基)碳二亚胺,Sodium Hydroxide体系中,用 四氢呋喃,1,4-二氧六环,甲醇,水,二甲基亚砜,N,N-二甲基甲酰胺 用作溶剂,化学反应 19.58H,反应生成N-((2-羟基-6-甲基-4-丙基-3-吡啶基)甲基)-1-异丙基-6-(2-(4-甲基-1-哌嗪基)-4-吡啶基)-1H-吲唑-4-甲酰胺
    参考文献:Identification Of Potent,Selective,Cell-Active Inhibitors Of The Histone Lysine Methyltransferase Ezh2
    标题:Identification Of Potent,Selective,Cell-Active Inhibitors Of The Histone Lysine Methyltransferase Ezh2
    摘要:The Histone H3-Lysine 27 (H3K27) Methyltransferase Ezh2 Plays A Critical Role In Regulating Gene Expression,And Its Aberrant Activity Is Linked To The Onset And Progression Of Cancer. As Part Of A Drug Discovery Program Targeting Ezh2,We Have Identified Highly Potent,Selective,Sam-Competitive,And Cell-Active Ezh2 Inhibitors,Including Gsk926 (3) And Gsk343 (6). These Compounds Are Small Molecule Chemical Tools That Would Be Useful To Further Explore The Biology Of Ezh2.
    Doi:10.1021/ml3003346

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Amatangelo MD, Garipov A, Li H, Conejo-Garcia JR, Speicher DW, Zhang R. Three-dimensional culture sensitizes epithelial ovarian cancer cells to EZH2 methyltransferase inhibition. Cell Cycle. 2013 Jun 10;12(13). [Epub ahead of print]

    合成参考文献


    参考文献:10.1182/blood-2016-09-741348
    摘要:Bujisic B, De Gassart A, Tallant R, Demaria O, Zaffalon L, Chelbi S, Gilliet M, Bertoni F, Martinon F. Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth. Blood. 2017 Apr 27;129(17):2420–8. doi: 10.1182/blood-2016-09-741348.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知